AU1660399A - Pharmaceutical preparations - Google Patents
Pharmaceutical preparationsInfo
- Publication number
- AU1660399A AU1660399A AU16603/99A AU1660399A AU1660399A AU 1660399 A AU1660399 A AU 1660399A AU 16603/99 A AU16603/99 A AU 16603/99A AU 1660399 A AU1660399 A AU 1660399A AU 1660399 A AU1660399 A AU 1660399A
- Authority
- AU
- Australia
- Prior art keywords
- pentaerythritol
- pharmaceutical preparations
- dinatrate
- pentaerythrito
- petn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to new, in particular orally administered pharmaceutical preparations containing, as pharmaceutical agent, pentaerythritol tetranitrate (PETN) or its metabolites pentaerythritol trinitrate, pentaerythritol dinatrate and pentaerythrito mononitrate, in amounts which guarantee the patient a sufficient dosage with one administering (per day).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19745618 | 1997-10-16 | ||
DE19745618 | 1997-10-16 | ||
PCT/DE1998/003030 WO1999018930A2 (en) | 1997-10-16 | 1998-10-16 | Pharmaceutical preparations |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1660399A true AU1660399A (en) | 1999-05-03 |
Family
ID=7845649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU16603/99A Abandoned AU1660399A (en) | 1997-10-16 | 1998-10-16 | Pharmaceutical preparations |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1023059B1 (en) |
AT (1) | ATE313323T1 (en) |
AU (1) | AU1660399A (en) |
CZ (1) | CZ301265B6 (en) |
DE (3) | DE59813300D1 (en) |
DK (1) | DK1023059T3 (en) |
ES (1) | ES2255193T3 (en) |
HU (1) | HUP0100634A3 (en) |
PL (1) | PL340386A1 (en) |
SK (1) | SK284769B6 (en) |
WO (1) | WO1999018930A2 (en) |
ZA (1) | ZA989356B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999067430A2 (en) * | 1998-06-24 | 1999-12-29 | Alpharma-Isis Gmbh & Co. Kg | Analytic substrates and antioxidative agents |
DE102008050597A1 (en) | 2008-10-09 | 2010-04-15 | Actavis Deutschland Gmbh & Co. Kg | Preparation, useful for treating and preventing idiopathic sudden sensorineural hearing loss, comprises pentaerythritol tetra-, pentaerythritol trinitrate, pentaerythritol dinitrate or pentaerythritol mononitrate, and an excipient |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3028307A (en) * | 1959-05-27 | 1962-04-03 | Warner Lambert Pharmaceutical | Pre-dried granulation and production of sublingual compressed organic nitrate tablets with selected solubilizing agents |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
ATE49503T1 (en) * | 1982-09-29 | 1990-02-15 | Ici America Inc | MEDICINAL COMPOSITIONS CONTAINING ORGANIC NITRATES STABLE TO DETONATION BY FIRE. |
DE3328094A1 (en) * | 1983-08-04 | 1985-02-21 | H. Trommsdorff GmbH & Co, 5110 Alsdorf | Desensitised pharmaceutical formulation of explosive nitric acid esters |
WO1990009171A1 (en) * | 1989-02-20 | 1990-08-23 | Soorianarain Baligadoo | Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker |
US5278192A (en) * | 1992-07-02 | 1994-01-11 | The Research Foundation Of State University Of New York | Method of vasodilator therapy for treating a patient with a condition |
DE4410997A1 (en) * | 1994-03-30 | 1995-10-26 | Isis Pharma Gmbh | Pharmaceutical preparations and drugs for the prevention and treatment of endothelial dysfunctions |
-
1998
- 1998-10-14 ZA ZA989356A patent/ZA989356B/en unknown
- 1998-10-16 HU HU0100634A patent/HUP0100634A3/en unknown
- 1998-10-16 AT AT98961013T patent/ATE313323T1/en active
- 1998-10-16 EP EP98961013A patent/EP1023059B1/en not_active Expired - Lifetime
- 1998-10-16 DE DE59813300T patent/DE59813300D1/en not_active Expired - Lifetime
- 1998-10-16 ES ES98961013T patent/ES2255193T3/en not_active Expired - Lifetime
- 1998-10-16 CZ CZ20001342A patent/CZ301265B6/en not_active IP Right Cessation
- 1998-10-16 DE DE29880094U patent/DE29880094U1/en not_active Expired - Lifetime
- 1998-10-16 DE DE19847781A patent/DE19847781A1/en not_active Withdrawn
- 1998-10-16 WO PCT/DE1998/003030 patent/WO1999018930A2/en active IP Right Grant
- 1998-10-16 AU AU16603/99A patent/AU1660399A/en not_active Abandoned
- 1998-10-16 SK SK538-2000A patent/SK284769B6/en not_active IP Right Cessation
- 1998-10-16 DK DK98961013T patent/DK1023059T3/en active
- 1998-10-16 PL PL98340386A patent/PL340386A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE59813300D1 (en) | 2006-01-26 |
HUP0100634A3 (en) | 2003-07-28 |
CZ301265B6 (en) | 2009-12-23 |
CZ20001342A3 (en) | 2000-09-13 |
WO1999018930A3 (en) | 1999-10-07 |
ZA989356B (en) | 1998-11-16 |
SK5382000A3 (en) | 2000-11-07 |
DE19847781A1 (en) | 1999-04-22 |
PL340386A1 (en) | 2001-01-29 |
EP1023059B1 (en) | 2005-12-21 |
EP1023059A2 (en) | 2000-08-02 |
WO1999018930A2 (en) | 1999-04-22 |
ATE313323T1 (en) | 2006-01-15 |
DK1023059T3 (en) | 2006-04-24 |
SK284769B6 (en) | 2005-11-03 |
DE29880094U1 (en) | 2000-05-18 |
ES2255193T3 (en) | 2006-06-16 |
HUP0100634A2 (en) | 2001-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2170255A1 (en) | Pharmaceutical Composition for Immunoenhancement Therapy | |
MY124695A (en) | Novel composition and use. | |
ZA962536B (en) | Pharmaceutical composition for transdermal administration. | |
AU641894B3 (en) | Methods for administration of taxol | |
WO2001090091A8 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
IL92007A0 (en) | Pharmaceutical compositions containing gestodene | |
IE843166L (en) | Pharmaceutical composition - xanthine derivatives | |
AU646230B2 (en) | Pharmaceutical compositions and methods for treating the symptoms of overindulgence | |
AU1890295A (en) | Piperidines and pyrrolidines | |
TW261615B (en) | ||
UA39101C2 (en) | derivatives of 11<font face="Symbol">b</font>-benzaldoxym-extra-4,9-dien, method for the preparation thereof and pharmaceutical composition with antiprogestin activity | |
WO1999063976A3 (en) | Liver-selective glucocorticoid antagonist for treating diabetes | |
CA2270177A1 (en) | Transdermal administration of ment | |
WO1994008613A3 (en) | Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy | |
CA2350659A1 (en) | Pharmaceutical composition for modified release insulin sensitiser | |
EP0683668A4 (en) | Compositions and methods for transdermal drug delivery. | |
HUP0203721A2 (en) | Novel hormonal composition and the use thereof | |
AU1660399A (en) | Pharmaceutical preparations | |
CO4940457A1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES | |
GR1002576B (en) | Pharmaceutical compositions and a process for the preparation thereof. | |
AR019331A2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN INSULIN SENSITIZER AND AN INSULIN SECRETAGOG. | |
MY115795A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | |
BR9714945A (en) | Topically applicable composition for introducing peptidaceous drugs into living organisms | |
AU6404798A (en) | Pharmaceutical composition for the administration of thiocolchicoside via the buccal mucosa | |
AU2624499A (en) | Oral compositions at low dosage of cytotoxic proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |